Newsroom All the latest news from the Pierre Fabre Group Page inner navigation PRESS RELEASES PRESS AREA NEWS PUBLICATIONS TWITTER Press releases Filter Year Year20242023202220212020 Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Écrit le Min Max Appliquer Press release Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories 1 March 2024 Press release Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies. 29 February 2024 Press release Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED. 16 February 2024 Load more Presse area Are you a journalist? Find all the press releases of the Pierre Fabre group. Join us News Filter Year Year20242023202220212020 Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Tags (field_news_tags) - Any -#CRCawarenessInternational Men's Day#OurBreastJourneyANNUAL REPORTSustainable developmentCOLLECTION PIERRE FABREConsortiumDIGITALLettre OuverteMelanomaPink OctoberOncologyStudyEventsPierre Fabre FoundationInnovationNominationsPartnershipsAwardsStrategyTalents Écrit le Min Max Appliquer Melanoma Events Melanoma Awareness Month – We Have Your Back 30 April 2024 #CRCawareness Events BLUE MARCH - Colorectal Cancer Awareness Month 1 March 2024 International Men's Day Events Men's Health Month 1 November 2023 Awards PIERRE FABRE CONFIRMED AS ONE OF THE WORLD’S BEST EMPLOYERS 13 October 2023 Load more Publications 25 August 2023 2023 Annual report of Pierre Fabre group 13 July 2022 2022 Integrated report of Pierre Fabre group Load more Follow our live news Social media type (field_social_media_type) FacebookInstagramTwitterLinkedin Appliquer Pierre Fabre Group @pierrefabregroup ⭐️ Discover the patient testimonial of Elise Hoogterp, patient advocate at France Asso Cancer et Peau. 13 hours ago Pierre Fabre Group @pierrefabregroup [Inno 360°] A-Derma innovates once again 🤩 4 days ago Pierre Fabre Group @pierrefabregroup What are the ABCDEs* of Melanoma ? Here’s a helpful guide to watch out for early signs. 👀 7 days ago Pierre Fabre Group @pierrefabregroup [Partners In Care] - Découvrez le podcast dédié aux acteurs Occitans 👏 8 days ago Pierre Fabre Group @pierrefabregroup 🔎 Have you checked all of your skin? Between your fingers and toes? On your back? 14 days ago Pierre Fabre Group @pierrefabregroup [Made in France] - Pierre Fabre Laboratories support 11 local athletes 🤝 18 days ago Pierre Fabre Group @pierrefabregroup [Inno 360°] Minimal ingredients, maximal tolerance 🤩 28 days ago Pierre Fabre Group @pierrefabregroup [Made in France] - Have you ever heard of the plant-based culinary universe? 32 days ago
Press release Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories 1 March 2024
Press release Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies. 29 February 2024
Press release Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED. 16 February 2024